BCM
BlueCrest Capital Management Portfolio holdings
AUM
$901M
1-Year Return
5.69%
This Quarter Return
+3.11%
1 Year Return
+5.69%
3 Year Return
+10.87%
5 Year Return
+26.99%
10 Year Return
+180.51%
AUM
$1.18B
AUM Growth
+$171M
(+17%)
Cap. Flow
+$73.4M
Cap. Flow
% of AUM
6.24%
Top 10 Holdings %
Top 10 Hldgs %
28.42%
Holding
714
New
325
Increased
97
Reduced
62
Closed
139
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 8.13% |
| 2 | Consumer Discretionary | 7.22% |
| 3 | Financials | 6.34% |
| 4 | Industrials | 6.2% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Prosperity Bancshares
PB
$6.46B
| $241K | 0.02% |
+3,416
| New | +$241K |
|
402
Reinsurance Group of America
RGA
$12.8B
| $241K | 0.02% |
+1,509
| New | +$241K |
|
403
Medtronic
MDT
$119B
| $240K | 0.02% |
+2,206
| New | +$240K |
|
|
DOVA
404
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $238K | 0.02% |
+8,500
| New | +$238K |
|
|
CZR
405
DELISTED
Caesars Entertainment Corporation
CZR
| $237K | 0.02% |
+20,351
| New | +$237K |
|
406
Affiliated Managers Group
AMG
$6.54B
| $235K | 0.02% |
+2,824
| New | +$235K |
|
407
Morgan Stanley
MS
$236B
| $235K | 0.02% |
+5,497
| New | +$235K |
|
408
Hanover Insurance
THG
$6.35B
| $235K | 0.02% |
+1,731
| New | +$235K |
|
409
Cabot Corp
CBT
$4.31B
| $234K | 0.02% |
+5,158
| New | +$234K |
|
410
Cirrus Logic
CRUS
$5.94B
| $234K | 0.02% |
+4,366
| New | +$234K |
|
411
M&T Bank
MTB
$31.2B
| $234K | 0.02% |
+1,480
| New | +$234K |
|
412
Thomson Reuters
TRI
$78.7B
| $234K | 0.02% |
+3,374
| New | +$234K |
|
413
The RealReal
REAL
$999M
| $233K | 0.02% |
10,400
-15,059
| -59% | -$337K |
|
414
PBF Energy
PBF
$3.3B
| $233K | 0.02% |
8,587
+284
| +3% | +$7.71K |
|
415
OR Royalties Inc.
OR
$6.48B
| $232K | 0.02% |
+24,975
| New | +$232K |
|
416
Manhattan Associates
MANH
$13B
| $230K | 0.02% |
+2,846
| New | +$230K |
|
|
CPE
417
DELISTED
Callon Petroleum Company
CPE
| $230K | 0.02% |
+5,300
| New | +$230K |
|
|
CBAY
418
DELISTED
Cymabay Therapeutics
CBAY
| $230K | 0.02% |
44,917
| – | – |
|
419
Autodesk
ADSK
$69.5B
| $228K | 0.02% |
1,543
-6,220
| -80% | -$919K |
|
420
Broadridge
BR
$29.4B
| $227K | 0.02% |
+1,821
| New | +$227K |
|
421
Harley-Davidson
HOG
$3.67B
| $227K | 0.02% |
+6,306
| New | +$227K |
|
422
TechnipFMC
FTI
$16B
| $226K | 0.02% |
+12,558
| New | +$226K |
|
423
Burlington
BURL
$18.4B
| $226K | 0.02% |
1,133
-845
| -43% | -$169K |
|
424
Corpay
CPAY
$22.4B
| $225K | 0.02% |
+785
| New | +$225K |
|
425
Norfolk Southern
NSC
$62.3B
| $224K | 0.02% |
+1,246
| New | +$224K |
|